Skip to content

Music to Reduce Use of Smoking in Patients With Schizophrenia

Music to Reduce Use of Smoking in Patients With Schizophrenia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03190161
Enrollment
2
Registered
2017-06-16
Start date
2017-03-09
Completion date
2018-09-17
Last updated
2019-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Dependence, Schizophrenia, Smoking, Tobacco

Keywords

Schizophrenia

Brief summary

The purpose of this study is to explore the impact of self-selected music listening which targets disrupting the reward process maintaining smoking and additionally attenuating the reward processing deficits associated with schizophrenia. Five participants with schizophrenia/schizoaffective disorder who smoke/nicotine will participate in an individual session of self-selected music listening for a half an hour.

Interventions

BEHAVIORALMusic session

Participants will be asked to refrain from smoking from 24 hours before the music listening session as confirmed by breath carbon monoxide level \<6 ppm on the day of the session. They will be contacted by phone or in person at the clinic as a reminder prior.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* clinician verification diagnosis of Schizophrenia or Schizoaffective Disorder * smoked at least 10 cigarettes per day for the past month * score of 4 or more on the Fagerstrom Test for Nicotine Dependence73 * psychiatric stability (e.g., no psychiatric hospitalizations within the last year, no expectation for medication change during study participation, no active suicidal ideation, no symptoms that interfere with ability to participate in study activities) * the capacity to participate in the informed consent process

Exclusion criteria

* being medically unstable (e.g., medical condition that requires frequent medical appointments or hospitalizations and interferes with ability to participate in study activities) * report active substance abuse or testing positive drug or alcohol use * taking bupropion, varenicline, nicotine replacement products and/or involved in any other smoking cessation treatment * participating in any treatment or activity that includes music as a focus * having a seizure disorder, other neurological illnesses, or a family history of seizures

Design outcomes

Primary

MeasureTime frameDescription
Snaith-Hamilton Pleasure Scale (SHAPS)1 DayMeasures Pleasure Pre Music Session
Snaith-Hamilton Pleasure Scale (SHAPS) Post Music Session1 DayMeasures Pleasure Post Music Session
Pleasure Rating Scale (PRS)1 DayMeasures Pleasure Pre Music Session
Pleasure Rating Scale (PRS) Post Music Session1 DayMeasures Pleasure Post Music Session
Questionnaire of Smoking Urges-Brief (QSU-B)1 DayMeasures Cravings Pre Music Session
Questionnaire of Smoking Urges-Brief (QSU-B) Post Music Session1 DayMeasures Cravings Post Music Session
Minnesota Nicotine Withdrawal Scale (MNWS)1 DayMeasures Withdrawal Pre Music Session and Post Music Session
Minnesota Nicotine Withdrawal Scale (MNWS) Post Music Session1 DayMeasures Withdrawal Post Music Session

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026